levodopa has been researched along with Diabetic Retinopathy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, MP; Nag, TC; Sen, S; Upreti, S | 1 |
| Ha, KS; Jeon, HY; Kim, M; Lee, AJ; Lee, YJ | 1 |
| Allen, RS; Bales, KL; Chesler, KC; Feola, AJ; Hendrick, AM; Iuvone, PM; Maa, AY; Mees, LM; Motz, CT; Olson, DE; Pardue, MT; Thule, PM | 1 |
| Wubben, TJ | 1 |
| Allen, RS; Chesler, K; Douglass, A; Feola, AJ; Motz, C; Pardue, MT; Vo, H | 1 |
| Aung, MH; Iuvone, PM; Kim, MK; Mees, L; Olson, DE; Pardue, MT; Pozdeyev, N; Thule, PM | 1 |
| Abey, J; Aseem, F; Aung, MH; Han, MK; Iuvone, PM; Obertone, TS; Pardue, MT; Park, HN; Thule, PM | 1 |
| Bluet-Pajot, MT; Drouin, P; Mejean, L; Rousselle, D; Schaub, C | 1 |
| Agrawal, JK; Kumar, V; Raman, RD; Singh, R | 1 |
| Berkowitz, O | 1 |
| Holland, PM; Landers, MB; Lebovitz, HE; Wolbarsht, ML | 1 |
| Jeske, W; Krassowski, J; Zgliczyński, S | 1 |
1 trial(s) available for levodopa and Diabetic Retinopathy
| Article | Year |
|---|---|
Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy.
Topics: Adult; Aged; Carbidopa; Diabetic Retinopathy; Drug Combinations; Electroretinography; Female; Humans; Levodopa; Male; Middle Aged | 2020 |
11 other study(ies) available for levodopa and Diabetic Retinopathy
| Article | Year |
|---|---|
Insulin like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor.
Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Dopamine; Endothelial Cells; Insulin-Like Growth Factor I; Levodopa; Rats; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2022 |
Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy.
Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Dopamine; Endothelial Cells; Humans; Levodopa; Mice; Retina; Retinal Vessels | 2022 |
Dopamine and Early Retinal Dysfunction in Diabetes: Insights From a Phase 1 Study.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Dopamine; Electroretinography; Humans; Levodopa; Retina | 2020 |
Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Levodopa; Neuroprotection; Rats | 2021 |
Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
Topics: Animals; Blood Glucose; Body Weight; Dark Adaptation; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dopamine; Dopamine Agents; Electroretinography; Female; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oscillometry; Retinal Rod Photoreceptor Cells; Tyrosine 3-Monooxygenase | 2018 |
Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Models, Animal; Dopamine; Female; Levodopa; Male; Mice; Mice, Knockout; Rats; Rats, Long-Evans; Retina | 2014 |
Growth hormone responses to the stimulation of hypothalamic glucoreceptors in diabetic retinopathy. Effects of catecholamine precursors and dopamine antagonists.
Topics: Adult; Diabetic Retinopathy; Female; Glucose; Growth Hormone; Humans; Hyperglycemia; Hypoglycemia; Hypothalamus; Levodopa; Male; Metoclopramide; Middle Aged; Receptors, Cell Surface; Stimulation, Chemical | 1982 |
Growth hormone and diabetic retinopathy.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Fasting; Growth Hormone; Humans; Levodopa; Middle Aged; Stimulation, Chemical | 1983 |
Diabetic retinopathy and growth hormone.
Topics: Diabetic Retinopathy; Growth Hormone; Humans; Levodopa | 1977 |
Levodopa-stimulated growth hormone secretion and diabetic retinopathy.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Stimulation, Chemical | 1976 |
Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Growth Hormone; Humans; Levodopa; Male; Thyrotropin-Releasing Hormone | 1992 |